| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |